Federal policy and quarterly results are setting the agenda for the cannabis industry. A first phase of new hemp restrictions has taken effect, while two multistate operators reported sharply different financial profiles amid consolidation and persistent market pressure.
Federal Hemp Restrictions Enter First Phase
A provision of federal law took effect November 12 that excludes certain cannabinoid products containing compounds not capable of being naturally produced by the cannabis plant from the legal definition of hemp. Products covered by the exclusion are instead classified as marijuana under the Controlled Substances Act.
Congress delayed most of the broader hemp-definition changes until December 11. Those remaining provisions include restrictions affecting a wider range of intoxicating hemp-derived consumer products, leaving businesses with less than a month to adjust unless lawmakers intervene again.
Why It Matters: Analysis: The staggered implementation creates immediate formulation and inventory risks for businesses selling synthetic cannabinoids while preserving only a short compliance window for the broader hemp beverage, edible and retail market. The December deadline remains one of the industry’s most consequential near-term regulatory events.
Source: Congressional Research Service
Ascend Wellness Revenue Reaches $130 Million
Ascend Wellness Holdings reported third-quarter net revenue of $130 million, up 4.2% from a year earlier and 3.1% sequentially. Adjusted EBITDA rose to $31.1 million, representing a 23.9% adjusted EBITDA margin, while the company recorded a GAAP net loss of $28 million.
The operator generated $5.4 million in operating cash flow despite making a $19.1 million semiannual interest payment. Ascend ended the quarter with $63.6 million in cash and $260.4 million in net debt, and said its retail footprint has expanded to 61 locations.
Why It Matters: Analysis: Ascend’s retail growth and positive operating cash generation demonstrate improving scale, but its net loss and debt load illustrate the financing constraints still facing large U.S. cannabis operators. Its performance will be watched as the company considers a potential major-exchange listing if federal policy permits.
Source: Ascend Wellness Holdings
Planet 13 Builds Florida Revenue Ahead of Vireo Merger Vote
Planet 13 reported third-quarter revenue of $23.1 million, a net loss of $6.4 million and an adjusted EBITDA loss of $200,000. Revenue increased 1% from the previous quarter but remained slightly below the year-earlier period.
Florida revenue increased 15.1% sequentially and 45% year over year, while lower Las Vegas tourist traffic and pricing pressure continued to weigh on Nevada operations. Planet 13 shareholders are scheduled to vote December 10 on the company’s proposed merger with Vireo Growth.
Why It Matters: Analysis: Florida’s improvement gives Planet 13 operational momentum before a consequential shareholder decision, but continuing losses and weakness at its flagship Las Vegas business reinforce the strategic case for consolidation. The vote will determine whether shareholders accept scale and balance-sheet support as the preferred path forward.
Source: Planet 13 Holdings
What We’re Watching
Watch for congressional efforts to modify or further delay the December 11 hemp deadline, additional cannabis earnings disclosures, and new details surrounding Planet 13’s December 10 merger vote. Businesses should also monitor whether federal or state agencies issue compliance guidance following the first phase of the hemp-definition change.
